July 15, 2008
BioNeutral Continues to Make Significant Advances With Its Ygiene(TM) Anti-Mold Formulation
NEWARK, N.J., July 15 /PRNewswire/ -- BioNeutral announces successful test results for its Ygiene(TM) Anti-Mold Formulation. Testing of BioNeutral's Anti-Mold formulation was conducted by Dr. Philip Tierno, the Principal Investigator on the project and Director of Clinical Microbiology and Diagnostic Immunology at Tisch Hospital, New York University Medical Center. These test results show that Ygiene(TM) Anti-Mold formulation totally eliminates Black Mold spores in seconds and also indicates that Ygiene(TM) is an effective sporicide. In contrast, a leading commercially available disinfectant, Lysol(R), did not eliminate Black Mold spores and was not sporicidal even after hours of contact. These results confirm that Ygiene(TM) consistently eradicates molds which pose a significant health risk.
Dr. Andy Kielbania, Chief Scientist at BioNeutral, stated that "we are extremely pleased that our robust technology platform which underpins the Ygiene(TM) Anti-Mold formulation allows us to easily design efficacious formulations for specific antimicrobial applications. In addition our Ygiene(TM) antimicrobials consistently outperform the current commercial competitive products which we have tested."In addition, Stephen Browand, Director of BioNeutral, is working with Dr. Tierno on the military-grade Ygiene (301).
Dr. Tierno has confirmed on Ygiene (301): "There is nothing better. (Virtually nothing compares with it.) There is nothing that works faster. (Kills in seconds) There is nothing that has a more complete kill. (Kills 100% of organisms) There is nothing wider in spectrum. (Kills any and all microbes) There is nothing that leaves the environment more green. (It eventually breaks down into innocuous substances.)"
Mr. Stephen Browand has previously reviewed the test results announced by Dr. Tierno regarding anthrax (attached video interview with Dr. Kielbania and Dr. Tierno). He will be meeting with military and government officials who have conveyed their interest in this powerful next-generation defensive tool.
YouTube link: http://www.youtube.com/watch?v=FOlnXLp1Itg About BioNeutral Laboratories Corporation
BioNeutral was organized in 2003 to commercialize a novel combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. The formulations are "Green" and include natural and common ingredients which are found in baby products and the foods we eat. These widely used compounds are combined in unique ways to create enhanced results.
BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. The products include BioNeutralizers and ChemoNeutralizers. BioNeutralizers disinfect, decontaminate and sterilize. BioNeutral believes it has the broadest-based, fastest acting, most effective and safest antimicrobial known. This class of products has important applications for consumers, healthcare and the military. ChemoNeutralizers irreversibly bind chemical contaminant and toxin molecules and render them harmless. Product applications include industrial pollution and protection against chemical weapons of mass destruction.
About Dr. Philip Tierno
Dr. Tierno is a consultant to BioNeutral. He is the Director of Clinical Microbiology and Diagnostic Immunology at Langone NYU Medical Center. He is also an Associate Professor at the New York University School of Medicine, NYU College of Dentistry and SUNY School of Optometry in New York City. Dr. Tierno is a member of the NYC Mayor's MRC (Medical Reserve Corps) and a former member of New York City's task force on bioterrorism. Dr. Tierno's work in the field of microbiology has resulted in numerous articles and texts that have been published in medical and scientific journals. He is co-editor and author of several books on microbes and biological protection.
About LYSOL(R) / Reckitt Benckiser Inc.
Reckitt Benckiser Inc. is a subsidiary of U.K.-based Reckitt Benckiser plc, the world leader in household cleaning (excluding laundry) and a major player in health and personal care. Reckitt Benckiser Inc. manufactures, markets and sells household, cleaning and specialty food products in North America, generating more than $1.8 billion in sales annually. These products include LYSOL(R) cleaners and disinfectants, Air Wick(R) air fresheners, Resolve(R) cleaners, Electrasol(R) automatic dishwasher detergent, Veet(R) depilatory, Jet-Dry(R) rinse agent, Spray 'n Wash(R) laundry stain removers, and French's(R) foods, including mustard and GourMayo(TM). Reckitt Benckiser's more than 20,000 employees conduct operations in 60 countries and sales in 180 countries, with global sales of more than $5 billion. For additional information about Reckitt Benckiser, visit http://www.reckittbenckiser.com/.
Contact: [email protected] Dr.Andy Kielbania Chief Scientist [email protected] Stephen J. Browand Director Governmental Affairs [email protected] Dr. Philip Tierno Consultant [email protected]
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com/.
BioNeutral Laboratories Corporation
CONTACT: Dr.Andy Kielbania, Chief Scientist, [email protected],or Stephen J. Browand, Director Governmental Affairs,[email protected], both of BioNeutral Laboratories Corporation,[email protected]; or Dr. Philip Tierno, Consultant,[email protected], for BioNeutral Laboratories Corporation
Web site: http://www.reckittbenckiser.com/